Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Gepotidacin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 76,065Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK reveals data on novel gonorrhoea drug gepotidacin
    GSK reveals data on novel gonorrhoea drug gepotidacin

    18 Apr 2024

    // PRESS RELEASE

    https://www.gsk.com/en-gb/media/press-releases/eagle-1-phase-iii-data-show-potential-for-gepotidacin-as-a-new-oral-treatment-option-for-uncomplicated-gc/

    PRESS RELEASE
    18 Apr 2024
    Share Share
    GSK Posts Positive Phase III Gonorrhea Results for Antibiotic Gepotidacin
    GSK Posts Positive Phase III Gonorrhea Results for Antibiotic Gepotidacin

    27 Feb 2024

    // BIOSPACE

    https://www.biospace.com/article/gsk-posts-positive-phase-iii-gonorrhea-results-for-antibiotic-gepotidacin/

    BIOSPACE
    27 Feb 2024
    Share Share
    GSK halts successful UTI trials early, preps FDA submission
    GSK halts successful UTI trials early, preps FDA submission

    04 Nov 2022

    // James Waldron FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/eagles-have-landed-gsk-halts-successful-uti-trials-early-preps-fda-submission

    James Waldron FIERCEBIOTECH
    04 Nov 2022
    Share Share